SARS-CoV-2

The inflammatory mechanism could also help explain other long COVID-19 symptoms.

Promising results in animal models help pave the way for clinical trials.

It could play a key role in the fight against many diseases.

Drug lessens harm and may serve as a potential COVID-19 therapy.

A component of some mouthwashes has an antiviral effect on SARS-CoV-2.

Around 60% of patients experienced digestive tract impacts.

The new approach successfully differentiates between antibodies against influenza and those attacking SARS-CoV-2, the virus that causes COVID-19.

Almost all post-COVID neuropathy is linked to a potentially treatable immune dysfunction.

No Omicron immunity without a booster.

The knowledge could help us to reduce the threat to humans of infectious diseases.

Findings could lead to the development of more effective vaccines and antibody treatments.

Mathematical simulations show the new approach may offer faster, cheaper, and more accurate detection.